Race Oncology Investor Briefing Session March 2025
Автор: Racura Oncology
Загружено: 2025-03-18
Просмотров: 1001
Описание:
In this webinar, Race Oncology (ASX:RAC) Executive Chair, Dr Peter Smith, and CEO and Managing Director Dr Daniel Tillett presented latest updates from the company, including:
Ethics approval for its Phase 1 clinical trial in solid tumours
Next steps for the trial
A live Q&A with investors.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: